← Back to Search

Procedure

Registry for flow diversion for Brain Aneurysm (FIAT Trial)

N/A

Waitlist Available

Led By Jean Raymond, MD

Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up discharge, 3 and 12 months

Awards & highlights

FIAT Trial Summary

This trial is testing whether a flow diverter, a new device used to treat intracranial aneurysms, is effective and has an acceptable rate of complications.

Eligible Conditions

Brain Aneurysm

FIAT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ discharge, 3 and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~discharge, 3 and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and discharge, 3 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

rate of success of therapy

Secondary outcome measures

angiographic outcome

modified Rankin score

rate of Adverse Events

+2 more

FIAT Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Registry for flow diversionExperimental Treatment1 Intervention

Flow diversion when randomization between flow diversion and best standard treatment is not possible and the only alternative is flow diversion for compassionate use. In this case there will be no random allocation but the patient will be entered into a registry

Group II: flow diversionActive Control1 Intervention

Flow diverters are low porosity braided endovascular stent devices. They can be used with or without coiling.

Group III: Best standard treatmentActive Control4 Interventions

Best standard treatment can by any of the standard management options: coiling, stenting plus coiling, surgical clipping, parent vessel occlusion, observation

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

flow diversion

2011

N/A

~330

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor

366 Previous Clinical Trials

129,314 Total Patients Enrolled

Centre de Recherche du Centre Hospitalier de l'Université de MontréalOTHER

51 Previous Clinical Trials

93,964 Total Patients Enrolled

Jean Raymond, MDPrincipal InvestigatorCentre Hospitalier de l'Université de Montréal - Hôpital Notre Dame

9 Previous Clinical Trials

3,992 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to participate in this medical experiment?

"This trial is prospectively enrolling 344 individuals between the ages of 18 and 75 who suffer from berry aneurysm. In order to meet inclusion criteria, patients must have a "difficult" intracranial aneurysm in which flow diversion can be seen as a suitable or best option for treatment by their clinician. These conditions may include symptomatic large or giant cavernous carotid, ophthalmic and vertebral aneurysms, fusiform intradural aneurysms, or recurring lesions that have not been addressed through coiling procedures previously. Moreover, this clinical trial will rarely accept"

Answered by AI

How many individuals have signed up to take part in this experiment?

"Affirmative. Based on the information provided by clinicaltrials.gov, this medical trial is presently recruiting patients. It was first posted on May 2nd 2011 and most recently updated July 19th 2022. The study necessitates 344 participants from 3 separate locations to be recruited."

Answered by AI

Is enrollment for this study still open?

"Clinicaltrials.gov shows that since it's initial posting on May 2nd 2011, this trial is presently seeking participants and was recently updated on July 19th 2022."

Answered by AI